HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When?

HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When? Banner

Add to Calendar HCV Treatment in Patients With Advanced Liver Disease: Who, How, and When? 10/1/2018 12:00:00 AM 9/30/2019 12:00:00 AM America/New_York false MM/DD/YYYY


Date & Location
Monday, October 1, 2018, 12:00 AM - Monday, September 30, 2019, 12:00 AM

Overview
This activity provides an overview of available therapeutic regimens for treatment-naïve patients with HCV infection and stage F2 or lower liver disease. Dr. Kwo also discusses the recommended monitoring that should occur during and after treatment, as well as the opportunity for cure among people who use injection drugs.
Registration

Go here to view this activity 

For questions or comments about this activity, please contact Med-IQ. Call (toll-free) 866 858 7434 or email info@med-iq.com.

To receive credit, read the introductory CME material, listen to the audiocast, and complete the evaluation, attestation, and post-test, answering at least 70% of the post-test questions correctly.


Accreditation

Accreditation Statement

In support of improving patient care, Indiana University School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

Indiana University School of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This CME activity has been developed in partnership with Med-IQ.

For questions about accessibility or to request accommodations please contact the IUSM CME office at 317-274-0104 or cme@iu.edu. One week advance notice will allow us to provide seamless access. Please ensure to specify the accommodations you need in order to participate.